pdufa.bio
Home › Decisions › MNKD 2026-05-29

MNKD FDA decision — May 29, 2026

✓ APPROVED

MannKind Corporation — Afrezza (Technosphere Insulin) - (INHALE-1) · Pediatric type 1/2 diabetes.

Run-up into the decision (T-120 → T+5)

PDUFA 5/29/26$6.21$2.2812/12/25
Daily close, T-120 (12/12/25) through T+5. Run-up high $6.21 on 2/6/26, low $2.28 on 3/27/26 (T-120 to T-1). FDA decision 5/29/26. Historical price action, not a forecast.

Key facts

FDA decision date2026-05-29
OutcomeApproved
Drug / candidateAfrezza (Technosphere Insulin) - (INHALE-1)
CompanyMannKind Corporation
120-day run-up (T-120→T-1)-36.3%
Not affiliated with or endorsed by the FDA. Informational and educational only — not investment advice. Verify against primary FDA / SEC / company filings. © 2026 pdufa.bio